Arbor Investment Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Arbor Investment Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$685,690
+5.9%
17,9500.0%0.12%
+5.3%
Q2 2023$647,457
-5.6%
17,9500.0%0.11%
-9.5%
Q1 2023$685,511
-32.9%
17,9500.0%0.13%
-39.7%
Q4 2022$1,021,355
+29.3%
17,9500.0%0.21%
+23.7%
Q2 2022$790,000
+10.3%
17,9500.0%0.17%
+23.4%
Q1 2022$716,000
-0.8%
17,9500.0%0.14%
+1.5%
Q4 2021$722,000
-1.1%
17,9500.0%0.14%
-8.2%
Q3 2021$730,000
-10.4%
17,9500.0%0.15%
-14.5%
Q2 2021$815,000
+9.0%
17,9500.0%0.17%
+2.4%
Q1 2021$748,000
-2.5%
17,9500.0%0.17%
-4.5%
Q4 2020$767,000
+62.5%
17,9500.0%0.18%
+43.1%
Q3 2020$472,000
-1.9%
17,9500.0%0.12%
-7.5%
Q2 2020$481,000
+48.9%
17,9500.0%0.13%
+24.3%
Q1 2020$323,000
+1.6%
17,9500.0%0.11%
+18.9%
Q4 2019$318,000
+14.4%
17,9500.0%0.09%
+7.1%
Q3 2019$278,000
-9.7%
17,9500.0%0.08%
-12.5%
Q2 2019$308,00017,9500.10%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders